Global Systemic Lupus Erythematosus Treatment Market Size, Share and Trends Analysis Report, By Treatment Type (Steroids, Antimalarials, Immunosuppressants, Antimetabolites, Alkylating Agents, and Monoclonal Antibodies), By Route of Administration (Sub-Cutaneous, Oral, and Intravenous), Forecast Period (2022-2028)

The global systemic lupus erythematosus treatment market is anticipated to grow at a 7.8% CAGR during the forecast period (2022-2028). A key driver of the systemic lupus erythematosus treatment market is the growing systemic lupus erythematosus throughout the globe. Other factors such as changing one’s lifestyle and having a good understanding of inflammatory autoimmune illnesses, disease testing, and treatment have a big impact on the industry growth. Furthermore, the continued involvement of major pharmaceutical and biotechnology companies in medications currently through clinical trials, which boosts demand, is a noteworthy advancement for this industry.

Furthermore, the global rise of the systemic lupus erythematosus treatment market is aided by the rising prevalence of autoimmune conditions. The market’s growth has been fueled by the introduction of significant pipeline agents, as well as recent drug approval processes. As a result, over the forecast period, the SLE treatment market is expected to rise at a quick pace.

Due to the widespread use of methotrexate, immunosuppressive drugs have the highest growth globally in lupus erythematosus, and the cost is relatively low in comparison to other treatments over the forecast period. Since they maintain the quality of the drugs, retail pharmacies have seen the fastest growth in global industry. For short-term diseases, patients regularly visit typical retail pharmacies. Complex and chronic illnesses are dealt with by specialty pharmacies. A more practical experience method is required for activities to identify retail pharmacies.

Some major players in the market include Anthera Pharmaceuticals, AstraZeneca, Aurinia Pharmaceuticals, GlaxoSmithKline plc, Merck & Co., Pfizer, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2021 The Australian Therapeutic Goods Administration has accepted a Category 1 application from GlaxoSmithKline plc and Medicines for Malaria Venture to expand the indication of single-dose Kozenis (tafenoquine) to pediatric populations for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Treatment Type
  • By Route of Administration
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Anthera Pharmaceuticals, AstraZeneca, Aurinia Pharmaceuticals, GlaxoSmithKline plc, Merck & Co., Pfizer, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Systemic Lupus Erythematosus Treatment Market Report by Segment

By Treatment Type

• Steroids
• Antimalarials
• Immunosuppressants
• Antimetabolites
• Alkylating Agents
• Monoclonal Antibodies

By Route of Administration

• Sub-Cutaneous
• Oral
• Intravenous

Global Systemic Lupus Erythematosus Treatment Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa